The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study
Articles > Article · 2024
Authors: HASAN ÇAĞRI YILDIRIM, YASİN KUTLU, EMEL MUTLU, MUSA BARIŞ AYKAN, MUSTAFA KORKMAZ, SELİM YALÇIN, TEOMAN ŞAKALAR, ÖZDE MELİSA CELAYİR, ERKAN KAYIKÇIOĞLU, FERİT ASLAN, EMRE HAFIZOĞLU, YUNUS EMRE ALTINTAŞ, MERVE KESKİNKILIÇ, Elvin Chalabiyev, Abdussamet Çelebi, BENGÜ DURSUN, Caner Kapar, MİRAÇ ÖZEN, ÖMER ACAR, ÖZGECAN DÜLGAR, ENGİN KUT, SEDAT BİTER, FATİH KUŞ, ELVINA ALMURADOVA, ATİKE PINAR ERDOĞAN, SERAY SARAY, DENİZ CAN GÜVEN, EDA TANRIKULU ŞİMŞEK, Necdet Üskent, YASEMİN KEMAL, Burcu ÇAKAR, ÖZGÜR AÇIKGÖZ, Sadettin Kılıçkap, SERCAN AKSOY
International Journal of Clinical Oncology, Journal Indexed in SCI Expanded, International, WoS, 2024, vol 29, pp 258-265